ProBiotix Health Plc (AQU:PBX)
London · Delayed Price · Currency is GBP · Price in GBX 7.75
0.00 (0.00%)
At close: Oct 21, 2025
ProBiotix Health Revenue
ProBiotix Health had revenue of 1.34M GBP in the half year ending June 30, 2025, with 143.48% growth. This brings the company's revenue in the last twelve months to 2.22M, up 4.42% year-over-year. In the year 2024, ProBiotix Health had annual revenue of 1.88M with 12.55% growth.
Revenue (ttm)
2.22M
Revenue Growth
+4.42%
P/S Ratio
5.52
Revenue / Employee
277.63K
Employees
8
Market Cap
12.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.88M | 210.00K | 12.55% |
| Dec 31, 2023 | 1.67M | 551.62K | 49.19% |
| Dec 31, 2022 | 1.12M | 21.25K | 1.93% |
| Dec 31, 2021 | 1.10M | 279.01K | 33.98% |
| Dec 31, 2020 | 821.13K | 453.90K | 123.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |